Pat McNally

Vice President Quality Assurance at Franklin Biolabs

Pat McNally possesses extensive experience in quality assurance and regulatory compliance within the pharmaceutical and biotechnology sectors. Currently serving as Vice President of Quality Assurance at Franklin Biolabs since January 2025, Pat has previously held key positions including Head of Quality for Cell and Gene Therapy at Catalent Pharma Solutions and Senior Director of Quality for Thermo Fisher Scientific’s Drug Product Division across multiple North American sites. With a strong foundation in quality system design and compliance, Pat has also operated as President of Padraig Consulting LLC, providing expert consulting services in quality system management and regulatory affairs. Pat's earlier roles include Site Quality Director at Mallinckrodt Pharmaceuticals and Director at QS Pharma, reinforcing a robust background in managing quality operations, continuous improvement initiatives, and strategic oversight in various organizations. Pat holds an MBA in Operations Management from Temple University and a BA in Biology from Rutgers University.

Location

Phoenixville, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Franklin Biolabs

Franklin Biolabs, a new genetic medicines contract research organization (CRO), will be the services and production arm, providing comprehensive solutions from discovery to development and distribution for the global genetic medicines industry. Alongside GEMMABio, Franklin Biolabs will advance cell & gene therapy research and deliver therapeutics to patients around the world significantly faster.